Back to Agenda
Session 7: Patient Labeling: Global View Part One
Session Chair(s)
Shinobu Uzu, PhD
Senior Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
This session provides updates on patient labeling in the EU, Canada, and Asia. EU Patient labeling initiatives will be discussed from the industry point of view, and Health Canada will discuss its ongoing initiative on Plain Language Labeling. In addition, the patient labeling landscape in Asia, including Japan, will be explained.
Speaker(s)
Megann Looker
Executive Director, Head of Global Labeling, Jazz Pharmaceuticals, United Kingdom
Patient Labeling Initiatives- EU
Michelle Remillard
Senior Policy Analyst, Pharmaceutical Drugs Directorate, Health Canada, Canada
Canada's Patient Medication Information (Part III of the Product Monograph)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Patient Labeling in Japan and the Asian Market
Have an account?